CLINICAL_TRIALS
trial_result
· 2015-11-26
Clinical Trial Update: Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia [Phase 3]
Summary
A Phase 3 efficacy study of OPC-34712 in adults with schizophrenia has completed and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Acute Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2015-11-26